Periplaneta americana extract alleviates steatohepatitis in a mouse model by modulating HMGB1-mediated inflammatory response

Yang Xiao, Chongqing Gao, Junru Wu, Jing Li, Lijuan Wang, Yang You, Tianqi Peng, Keke Zhang, Mingrong Cao, Jian HongFrontiers in Pharmacology 2022 · DOI

This study investigates the therapeutic potential of Ganlong capsule (GLC)—an extract derived from the American cockroach (Periplaneta americana)—in treating steatohepatitis. By using a mouse model that combines alcohol consumption with a high-fat, high-cholesterol diet, researchers demonstrated that GLC reduces liver fat, oxidative stress, and inflammation by blocking the release of a key "danger signal" protein called HMGB1.

TL;DR

Researchers found that Ganlong capsule (GLC), a cockroach-derived extract, effectively alleviates steatohepatitis in mice by inhibiting the HMGB1-mediated inflammatory cascade. It works by preventing damaged liver cells from triggering pro-inflammatory macrophage activity, suggesting a novel pharmacological path for treating metabolic and alcohol-induced liver diseases.

What Problem Does This Paper Address?

Chronic liver disease (CLD) affects nearly 844 million people worldwide. The two primary drivers are alcohol abuse and obesity, which often act synergistically to accelerate liver damage—a phenomenon known as the "two-hit" hypothesis. This progression from simple fatty liver (steatosis) to inflammation (steatohepatitis) and eventually cirrhosis lacks effective pharmacological treatments beyond lifestyle changes or corticosteroids.

While Periplaneta americana has been used in traditional medicine for wound healing and hepatitis B, its efficacy against steatohepatitis (specifically the combined insult of fat and alcohol) was previously uncharacterized. The authors sought to determine if GLC could interrupt the inflammatory signals that turn a fatty liver into a diseased one.

Methods

The researchers employed a multi-faceted approach combining animal models, cell cultures, and bioinformatics:

  • In Vivo Model: C57BL/6J mice were fed an "EHFD" (Ethanol + High-Fat High-Cholesterol Diet) to mimic human metabolic and alcoholic stress. They were treated with varying doses of GLC (60 or 120 mg/kg).
  • In Vitro "GLC Serum" Method: To better simulate how the body metabolizes the drug, researchers treated mice with GLC, collected their serum, and applied this "GLC serum" to hepatocyte (NCTC1469) and macrophage (J774A.1) cell lines.
  • Co-culture System: They used a co-culture model to observe how damaged hepatocytes communicate with macrophages, specifically looking at how "danger signals" from dying cells trigger immune responses.
  • Molecular Analysis: Techniques included qRT-PCR for gene expression, Western blotting for protein pathways (TLR4/NF-κB), and immunofluorescence to track ROS (reactive oxygen species) and protein translocation.

Datasets

  • Primary Experimental Data: Original data generated from mouse tissues and cell lines.
  • Public Bioinformatic Data: The authors utilized the GEO database (GSE28619), a cDNA microarray dataset of patients with alcoholic hepatitis, to correlate HMGB1 expression with M1 macrophage markers in humans, validating their mouse-model findings.

Key Insights and Ideas

  • HMGB1 as the "Master Switch": The study identifies High Mobility Group Box 1 (HMGB1) as a critical mediator. Normally found in the nucleus, HMGB1 is released into the extracellular space when hepatocytes are stressed or dying. It acts as a Damage-Associated Molecular Pattern (DAMP), essentially a "flare" that alerts the immune system.
  • Interrupting the M1 Polarization: GLC doesn't just "lower inflammation" generally; it specifically prevents macrophages from polarizing into the "M1" (pro-inflammatory) state. By keeping HMGB1 inside the damaged hepatocytes, GLC prevents the activation of the TLR4/NF-κB pathway in nearby immune cells.
  • Dual Action on Metabolism and Immunity: GLC showed a "two-pronged" benefit: it improved lipid metabolism (upregulating fatty acid oxidation genes like Cpt1a) while simultaneously dampening the immune system's overreaction to cell death.

Key Results

  • Reduced Liver Injury: GLC treatment significantly lowered serum levels of ALT and AST (key biomarkers of liver damage) and reduced the "liver index" (liver weight relative to body weight).
  • Lipid Clearance: Histological staining (Oil Red O and Nile Red) showed a dramatic reduction in lipid droplets. GLC downregulated lipogenic genes (Cd36, Fasn, Scd1) and upregulated genes involved in breaking down fats.
  • Anti-Inflammatory Effect: GLC significantly reduced the expression of pro-inflammatory cytokines including IL-1β, IL-6, and TNF-α.
  • Pathway Inhibition: The study confirmed that GLC blocks the translocation of HMGB1 from the nucleus to the cytoplasm and inhibits the phosphorylation of NF-κB p65, effectively shutting down the downstream inflammatory signaling.

Limitations and Future Work

The authors acknowledge that GLC is a complex crude extract containing various polysaccharides, peptides, and steroids. Identifying the specific bioactive molecule(s) responsible for the HMGB1 inhibition remains a task for future research. Additionally, while the mouse EHFD model is a robust surrogate, human clinical trials are necessary to confirm if these cockroach-derived compounds can safely translate to human therapy for NASH (non-alcoholic steatohepatitis) or ASH (alcoholic steatohepatitis).

Summary updated

Abstract

Alcoholic abuse and obesity are the most common lifestyle implications of chronic liver injury, and always act synergistically to increase the risk of mortality. <i>Periplaneta americana</i> has a long history of being applied in medicine, including wound healing, antitumor, antibacterial, antiviral, antifibrotic, and cardiomyocyte-protecting. Ganlong capsule (GLC), a natural prescription drug extracted from <i>Periplaneta americana</i>, has been widely used in HBV-related symptoms. However, the anti-steatohepatitis efficacy and mechanisms of GLC have not yet been characterized. Here, we found the protective effect of GLC on the development of hepatic steatosis, oxidative stress, and inflammation <i>in vivo</i> under alcohol exposure combined with a high-fat and high-cholesterol diet (HFHC). Consistently, GLC exhibited a hepatoprotective property by preventing hepatocytes from oxidative stress injury and lipid accumulation <i>in vitro</i>. In addition, it exerted an anti-inflammation characteristic by reducing macrophage recruitment and decreasing the expression of pro-inflammatory genes <i>in vivo</i> and <i>in vitro</i>. Mechanically, GLC serum, isolated from GLC-treated mice, reduced extracellular high-mobility group box 1 (HMGB1) of dying hepatocytes; and suppressed subsequent M1 polarization of macrophages in the co-culture system. Furthermore, GLC serum inhibited inflammatory response <i>via</i> suppressing the HMGB1 release and blocking the downstream TLR4/NF-kB pathway. Collectively, GLC alleviates steatohepatitis induced by alcohol consumption and obesity through inhibition of the HMGB1-mediated inflammatory cascade. GLC might be a therapeutic candidate for the treatment of steatohepatitis developed by alcohol abuse and metabolic disorders.
BibTeX
@inproceedings{xiao2022periplaneta,
  author = {Yang Xiao and Chongqing Gao and Junru Wu and Jing Li and Lijuan Wang and Yang You and Tianqi Peng and Keke Zhang and Mingrong Cao and Jian Hong},
  title = {{Periplaneta americana extract alleviates steatohepatitis in a mouse model by modulating HMGB1-mediated inflammatory response}},
  booktitle = {Frontiers in Pharmacology},
  year = {2022},
  doi = {10.3389/fphar.2022.995523},
}
Figure